Łobejko, K. et al. 2025. Bilirubin and uric acid serum levels in patients with relapsing-remitting multiple sclerosis after the first phase of cladribine treatment. Current Issues in Pharmacy and Medical Sciences. 23, 1 (Apr. 2025), 137–142.